Clinical Trial Update: Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 1PC111 with pitavastatin and ezetimibe in primary hypercholesterolemia or mixed dyslipidemia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Dyslipidemias

Drugs mentioned

• 1PC111
• EZETIMIBE (EZETIMIBE)
• Pitavastatin (Pitavastatin)

Snippet

Sponsor: Orient Pharma Co., Ltd. | Conditions: Primary Hypercholesterolemia, Mixed Dyslipidemias | Phase 3 | Status: COMPLETED